Premenstrual syndrome.
The advances in the careful screening and diagnosis of women with PMS has led to the ability to conduct epidemiologic, etiologic, and treatment studies in well-defined samples of women. Prospective symptom charting, scoring methods, and careful clinical psychiatric and medical evaluation are necessary to rule out concurrent psychiatric and medical disorders. Studies of women with PMDD have suggested several promising pharmacologic treatment options. Whether these treatment options are also successful for women with milder premenstrual symptoms, with premenstrual exacerbation of underlying conditions, or with premenstrual symptoms superimposed on underlying psychiatric and medical conditions remains to be studied. Treatment of premenstrual symptoms by pharmacologic or nonpharmacologic methods may be unsuccessful if the underlying psychiatric or medical condition is not addressed first.
Pearlstein
T
T
Department of Psychiatry and Human Behavior, Brown University School of Medicine, Providence, Rhode Island, USA.
Stone
A B
AB
D000293:Adolescent; D000328:Adult; D001008:Anxiety Disorders / Q000175:diagnosis; D001249:Asthma / Q000209:etiology; D001327:Autoimmune Diseases / Q000175:diagnosis; D001714:Bipolar Disorder / Q000175:diagnosis; D003863:Depression / Q000175:diagnosis; D003937:Diagnosis, Differential; D004700:Endocrine System Diseases / Q000175:diagnosis; D004827:Epilepsy / Q000209:etiology; D001068:Feeding and Eating Disorders / Q000175:diagnosis; D005260:Female; D006261:Headache / Q000209:etiology; D006801:Humans; D008875:Middle Aged; D011293:Premenstrual Syndrome / Q000175:diagnosis*; D012559:Schizophrenia / Q000175:diagnosis; D019966:Substance-Related Disorders / Q000175:diagnosis